NUVB - Nuvation Bio Price-to-Projected Revenue Ratio

Nuvation Corp (NUVB) - corporate logo

Can the academic culture of Nuvation Bio Inc. (NUVB) and its bet on talent drive growth? This forward price-to-sales chart provides the answer, with the metric currently standing at 7.00. High costs and patent risks create steep barriers to entry. Meanwhile, Nuvation Bio Inc. (NUVB) is implementing robotic molecule screening to combat resistant tumors, optimizing its laboratory processes.

Nuvation Bio Inc - NUVB Projected Price to Revenue (period 08/06/2024 - 11/14/2026)

Comprehensive metric breakdowns and analytics for Nuvation Bio (NUVB)

- market price and analyst price targets:
Price Chart Nuvation Pharma|NUVB - Price Target Chart
- market capitalization statistics:
Market Value Nuvation Corp|NUVB - Total Enterprise Value
- book value of equity indicators:
Book Value per Share Nuvation Bio|NUVB - Book Value of Business|Market Cap to Net Assets Ratio nuvationbio.com|NUVB - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Nuvation Bio Inc.|NUVB - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Nuvation Bio Inc.|NUVB - Company Cumulative Indebtedness|Debts to Book Capitalization Nuvation Bio Inc|NUVB - Company Long-Term Loans and Borrowings|Company Short-Term Debts Nuvation Bio|Quick Liquidity nuvationbio.com
- financial results and valuation multiples details:
NUVB - Final Profit|Projected Future Earnings Nuvation Bio Inc.|NUVB - P/E Multiple|Future Price to Earnings Nuvation Pharma|NUVB - Market Cap to Earnings and Growth Ratio|Enterprise Value to EBITDA Ratio Nuvation Corp|NUVB - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Nuvation Bio|NUVB - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months nuvationbio.com|NUVB - Earnings growth in current year|Expected earnings per share growth for next year Nuvation Bio Inc.
- revenue and sales proceeds data:
NUVB - Company Revenue|Projected Sales Volume Nuvation Bio Inc|NUVB - P/S Multiple|Forward Price-to-Revenue Multiple Nuvation Corp
General company analysis:Nuvation Pharma NUVB
Manufactured products of nuvationbio.com

To protect capital amid uncertainty, it is critical to distinguish between undervaluation and systemic business decline. The forward P/S ratio compares market value with expected revenue, revealing the extent of an asset's overvaluation. Analyzing the projected price-to-sales ratio helps determine whether a price drop is a "value trap." For Nuvation Bio Inc. (NUVB), which has no commercial products, this indicator reflects the speculative value of future developments supported by current investment capital.

Key competitors

Price-to-Projected Revenue Ratio Incyte Corp. INCY|HUTCHMED Ltd (HCM) - Market Cap to Future Revenue Ratio|DAWN - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Monopar Therapeutics|INBX: Forward P/S Multiple|Projected Price to Revenue I-Mab IMAB|Forward Price-to-Revenue Multiple FENC|Market Cap to Future Revenue Ratio Heron Therapeutics, Inc. HRTX|Forward Price-to-Revenue Multiple NVCT (Nuvectis Pharma, Inc.)|CHRS (Coherus BioSciences) - Forward Price to Sales|Corbus Pharmaceuticals - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio CRDF (Cardiff Oncology Corp)|BeyondSpring Pharma - Forward P/S Multiple|Forward Price to Sales BCAB (bioatla.com)|LIXT: Forward P/S Multiple|Market Cap to Future Revenue Ratio Citius Pharma (CTXR)|Price-to-Projected Revenue Ratio Cellectar Biosciences, Inc.|BLRX: Forward Price to Sales|Forward P/S Multiple CANF|Forward P/S Multiple Aprea Therapeutics Inc. (APRE)|Price-to-Projected Revenue Ratio Kazia Therapeutics Ltd KZIA|SLXN (silexion.com) - Future Price to Revenue|NCNA: Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio Chimerix|CYCC: Forward P/S Multiple|Projected Price to Revenue G1 Therapeutics Inc. GTHX|Price-to-Projected Revenue Ratio Kronos Bio, Inc.|kintara.com (KTRA) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ONCT|PRTG (Portage) - Forward Price to Sales